S5 Ep24: Mayer on the Optimization of SERDs in ER+ Breast Cancer
OncLive® On Air - Podcast készítő OncLive® On Air
Dr. Mayer discusses the mechanism of action of SERDs in ER-positive breast cancer, highlighted data from the AMEERA-1 trial with amcenestrant and palbociclib, and details future research efforts with SERDs.
